Immunohistochemical demonstration of bone morphogenetic protein in odontogenic tumors

Journal of Oral Pathology and Medicine

Volumn 26, Issue 6, 1997, Pages 273-277

  Gao, Y H ^a,b   Yang, L J ^a   Yamaguchi, A ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Immunohistochemistry; Odontogenic tumors

Indexed keywords

EID: 0031193335     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1997.tb01236.x     Document Type: Article

References (28)

1. ROSEN V, COX K, HATTERSLEY G. Bone morphogenetic protein. In: BILEZIKIAN JP, RAISZ LG, RODAN GA, eds. Principles of bone biology. San Diego, California: Academic Press, 1996; 661-72.
2. YANG LJ, JIN Y. Immunohistochemical observation on bone morphogenetic protein in normal and abnormal conditions. Clin Orthop 1990; 257: 249-56.
3. YANG LJ, GAO YH. Bovine bone morphogenetic protein-induced dentinogenesis. Clin Orthop 1993; 295: 305-12.
4. KRAMER IRH, PINDBORO JJ, SHEAR M. World Health Organization International Histological Classification of Tumors: Histological typing of odontogenic tumors. Berlin: Springer-Verlag, 1992: 7-11.
5. URIST MR, HUO YK, BROWNELL AG, et al. Purification of bovine BMP by hydroxyapatite chromatography. Proc Natl Acad Sci USA 1984; 81: 371-5.
6. FAN DM, YANG LJ, JIN Y, ZHANG XY. Preparation and significance of the monoclonal antibody against the bioactive group of bone morphogenetic protein (BMP). J 4th Mili Med Univ 1989; 10: 215-6.
7. RAVAL R, HSU HHT, SCHNEIDER DJ, et al Expression of bone morphogenetic proteins by osleoinductive and non-osteoinductive human osteosarcoma cells. J Dent Res 1996; 75: 1518-23.
8. ANDERSON CH, Hsu HHT, RAVAL P, et al. The mechanism of bone induction and bone healing by human osteosarcoma cell extracts. Clin Orthop 1995; 313: 129-34.
9. BENTZ H, THOMPSON AY, ARMSTRONG R, CHANG R-J, PIEZ KA, ROSEN DM. Transforming growth factor-beta2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3. Matrix 1991; 11: 269-75.
10. HSU SM, RAINE L, FANGER H Use of avidin-biotin-peroxidase compound (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
11. VAINIO S, KARAVANOVA I, JOWETT A, THESLEFF I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 1993; 75: 45-58.
12. BITGOOD MJ, MCMAHON AP. Hedgehon and BMP genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995; 172: 126-38.
13. YOSHIKAWA H, WOLFGANG JR, JOSEPH ML, et al. Immunohistochemical detection of bone morphogenetic proteins in bone and soft tissue sarcomas. Cancer 1994; 74: 842-7.
14. HATAKEYAMA S, SATOH M, YOSHIMURA N, OTSU T. Immunohistochemical location of bone morphogenetic proteins in salivary gland pleomorphic adenoma. J Oral Pathol Med 1994; 23: 232-6.
15. HARRIS SE, HARRIS MA, MAHY P, WOZNEY J, FENG JQ, MUNDY GR. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 1994; 24: 204-11.
16. BENTLEY H, HAMDY FC, HART KA, et al. Expression of bone morphogenetic proteins in human prostate adenocarcinoma and benign prostate hyperplasia. Br J Cancer 1992; 66: 1159-63.
17. SHIMIZU K, YOSHIKAWA H, MATSUI M, MASUHARA K, TAKAOKA K. Periosteal and intratumorous bone formation in athymic nude mice by Chinese hamster ovary tumors expressing murine bone morphogenetic protein-4. Clin Orthop 1994; 300: 274-80.
18. YOSHIKAMA H, TAKAOKA K, HAMADA H, ONO K. Clinical significance of bone morphogenetic activity in osteosarcoma: a study of 20 cases. Cancer 1985; 56: 1682-7.
19. YOSHIKAWA H, TAKAOKA K, MASUHARA K, ONO K, SAKAMOTO Y. Prognostic significance of bone morphogenetic protein in osteosarcoma tissue. Cancer 1988; 61: 569-73.
20. JIN Y, YANG LJ. The relationship between bone morphogenetic protein and neoplastic bone disease. Clin Orthop 1990; 259: 233-8.
21. JIN Y, YANG LJ. Immunohistochemical analysis of bone morphogenetic protein (BMP) in osteosarcoma. J Oral Pathol Med 1990; 19: 152-4.
22. YOSHIKAWA H, RETTIG WJ, TAKAOKA K, et al. Expression of bone morphogenetic protein in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer 1994; 73: 85-91.
23. ANDREWS PW, DAMIJANOV I, BERENDS J, et al. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab Invest 1994; 71: 243-51.
24. BLESSING M, NANNEY LB, KING LE, HOGAN BL. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-b related transgene. Teratog Carcinog Mutagen 1995; 15: 11-21.
25. BHASKAR SN. Synopsis of oral pathology. St Louis: CV Mosby, 1981: 250-90.
26. VAN WYK CW, VAN DER VYVER PC Ameloblastic fibroma with dentinoid formation/immature dentinoma. A microscopy and ultrastructural study of the epithelial-connective tissue interface. J Oral Pathol 1983; 12: 37-46.
27. HEIKINHEIMO K. Stage-specific expression of decapentaplegic-Vg-related genes 2,4, and 6 (bone morphogenetic protein 2, 4 and 6) during human tooth morphogenesis. J Dent Res 1994; 73: 590-7.
28. NAKASHIMA M. Induction of dentin formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and -4. J Dent Res 1994; 73: 1515-22.